News

(Wed, 01 Apr 2009 10:18:31)

Congratulations to Trudy Kuipers–de Groot of Astellas Pharma.
An ipod touch will be with you shortly......

Commiserations to all those who entered but did not win.

(Thu, 11 Dec 2008 10:02:08)

t+ Medical receives investment from Vodafone Ventures to help
develop the potential of the mobile health (mHealth) market

Vodafone Ventures Ltd, the corporate venture capital arm of Vodafone Group, has
made an undisclosed investment in t+ Medical, the leading provider of mobile phone
based technology used to transfer patient biometric data.

The t+ technology is currently used for the management of long-term health conditions
and helps thousands of people in the UK manage their conditions each year.

The additional funding from Vodafone Ventures will enable t+ Medical to accelerate the
roll-out of its mPRO™ (mobile patient reported outcomes) platform which has been
specially designed for use in clinical trials.

The mPRO™ platform offers a number of clear benefits:

• speed new drugs to market by reducing the all important timelines between drug
discovery and launch

• help increase patient safety by eliminating the inaccuracies caused by subjects
not completing their paper diaries

• help pharmaceutical companies move towards a technological system of patient
data capture as recommended by the FDA

• real-time analysis of clinical data enabling early adaptations to trials

• familiar mobile phone hardware delivers high levels of compliance among users

The technology enables the easy collection of patient data in clinical trials via a mobile
device. Data is entered by subjects into an interactive diary programme on their mobile.
Using secure mobile networks, the information is automatically and instantly downloaded
to t+ servers where it can be analysed, ensuring any significance in the results is identified
at the earliest possible opportunity.

Tim Clover, CEO of t+ Medical said: “The provision of healthcare services and clinical
trials through mobile technology offers a scalable platform to allow large volumes of
patient data to be securely transferred and analysed in real-time. This investment from
Vodafone Ventures will help us to further drive the roll out of remote patient
management solutions, to offer cost savings and improved clinical outcomes to
customers around the world.”

Peters Suh, President of Vodafone Ventures said: “This investment will help to
ensure that t+ Medical is able to deliver on its potential while bringing greater scale to
the mHealth market.”

London based legal firm Pillsbury Winthrop Shaw Pittman LLP advised Vodafone.

(Thu, 11 Sep 2008 08:39:51)

t+ Clinical’s mPRO (mobile patient reported outcomes) solution is short-listed for the Good Clinical Practice Journal Awards 2008.

The mPRO solution runs over the world’s largest data infrastructure, operates on mobile phones in every geography and delivers familiar, high compliance technology to study subjects worldwide. Using a unique yet practical method of gathering electronic patient recorded data through mobile phones, t+ Clinical are able to offer fast rollout within days of a finalised study, combined with real time analysis of primary outcomes.

The annual Good Clinical Practice Journal Awards are designed to recognise the remarkable achievements of individuals and organisations working in the clinical trial industry. t+ Clinical are short-listed under ‘Best technological development in clinical trials’ and in this category judges are looking for the product that represents the best advance in supporting clinical trial management.

“Outstanding. Exemplary. Impressive.” These are just some of the comments received from the judges about this years GCPj entries. Proving once again that the clinical trials sector is buzzing with innovation and a continued commitment to improving trial processes.

About t+ Clinical: t+ Clinical was established in 2007 as a subsidiary to t+ Medical Holdings, to offer data capture solutions to pharmaceutical customers for late stage clinical trials. The vision of t+ Clinical is to enable the drug discovery process to move as quickly and accurately as possible through mobile phone based, late stage clinical trials. By ensuring that every stage of data collection and analysis is as efficient as possible, high standard results are delivered in the shortest time.

For further information please e mail info@tplusclinical.com or call
Anna Griffiths +44 (0) 1235 432050

www.tplusclinical.com

www.gcpjawards.com

(Tue, 08 Jul 2008 11:37:36)

Oxford, UK-July 8th 2008, t+ Medical is delighted to announce the acquisition of Vivatec Ltd. Following a period of rapid expansion including a successful launch of t+ Clinical into the clinical trial market, the purchase of Vivatec will allow t+ Medical to aggressively expand by offering an integrated solution covering medical devices, communication technology and nurse call centres to its customers.

t+ Medical is the leading global supplier of mobile phone based technology for capturing patient data for long term condition management and clinical trials. t+ Medical’s clinically validated solution offers a unique combination of simplicity and effectiveness which delivers impressive economic and healthcare returns for its customers.

Vivatec is one of only 13 companies to be selected as a supply partner to the NHS Purchasing and Supply Agency (NHS PASA) for telecare products and services. The company supplies two of the three Department of Health funded Whole System Demonstrators which are evaluating remote monitoring technologies across 6,000 patients in the UK. The company will now further develop its position as a leading supplier of a complete spectrum of patient monitoring devices.

In a joint statement Tim Clover, CEO of t+ Medical Holdings and Andrew Hall, founder and Managing Director of Vivatec said “The combination of two successful companies creates a complete solution for both healthcare and drug discovery organisations. This acquisition enables t+ Medical to expand its current offering by adding an extensive range of medical device technologies to its remote patient monitoring solutions and ePRO technologies for clinical trials. The synergy between the two companies provides an ideal base from which to further deliver the benefits of mobile telephones in healthcare and we expect that this latest development will enable the rapid growth that we have experienced to continue.”

(Thu, 19 Jun 2008 15:11:56)

t+ Clinical launch a mobile phone based mPRO (mobile patient recorded outcomes) solution at the 44th annual meeting of the Drug Information Association in Boston USA, 22nd to 26th June 2008.

t+ Clinical is an electronic patient reported outcome solution that runs over the worlds largest data infrastructure. Using a unique mobile phone based data capture solution, t+ Clinical are able to offer fast rollout within days of a finalised study, combined with real time analysis of primary outcomes.

The DIA was the first opportunity to demonstrate the technology to potential customers, and t+ Clinical are looking forwards to introducing their unique product into the world of clinical trials.

President and CEO of t+ Clinical Tim Clover said “By effectively using a disposable cell phone handset and an automated custom questionnaire engine we will deliver substantial benefits in both speed of rollout and real-time technical performance to CRO’s and drug discovery companies worldwide. Using such familiar technology we have been able to generate almost - subject compliance, offering further potential savings in subject populations and study duration.”

About t+ Clinical: t+ Clinical was established in 2007 as a subsidiary to t+ Medical Holdings, to offer data capture solutions to pharmaceutical customers for late stage clinical trials. The vision of t+ Clinical is to enable the drug discovery process to move as quickly and accurately as possible through mobile phone based, late stage clinical trials. By ensuring that every stage of data collection and analysis is as efficient as possible, high standard results are delivered in the shortest time.

For further information please e mail info@tplusclinical.com or call
UK-Anna Griffiths +44 (0) 1235 432056
USA-Kristen Patel 910.442.3040

www.tplusclinical.com